Pharmacological effect
1. Glucose-dependent insulin secretion promotion: When blood sugar is high, it stimulates pancreatic beta cells to release insulin; In a hypoglycemic state, insulin is not stimulated, and the risk of hypoglycemia is low.
2. Inhibit glucagon release: Reduce liver sugar output and lower postprandial blood sugar.
3. It delays gastric emptying, acts on the appetite center of the hypothalamus, enhances satiety, suppresses appetite, reduces total calorie intake, and achieves weight loss.
4. Cardiovascular protection benefits: It is used for type 2 diabetes complicated with cardiovascular diseases, reducing the risk of major adverse cardiovascular events (myocardial infarction, stroke, cardiovascular death).
IDA